Brinzolamide
Brand name: Azopt
Rank #424 of 500 drugs by total cost
$20.1M
Total Cost
57,322
Total Claims
$20.1M
Total Cost
2,047
Prescribers
$350
Cost per Claim
7,922
Beneficiaries
107,349
30-Day Fills
$9,811
Avg Cost/Provider
28
Avg Claims/Provider
About Brinzolamide
Brinzolamide (sold as Azopt) was prescribed 57,322 times by 2,047 Medicare Part D providers in 2023, costing the program $20.1M. At $350 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 421 | Sodium, Potassium,mag Sulfates (Sod Sulf-Potass Sulf-Mag Sulf) | $20.7M | 246,742 |
| 422 | Efinaconazole (Jublia) | $20.4M | 15,425 |
| 423 | Mometasone/Formoterol (Dulera) | $20.4M | 46,961 |
| 424 | Brinzolamide (Azopt) | $20.1M | 57,322 |
| 425 | Clobazam (Clobazam) | $19.8M | 58,877 |
| 426 | Fluorouracil (Fluorouracil) | $19.5M | 220,445 |
| 427 | Ertapenem Sodium (Ertapenem) | $19.4M | 36,784 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology